ArticleBlood advances2025

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS.

Thomas Cluzeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.